AVI BioPharma, Inc.
Antisense approach to transplant acceptance works by regulating lymphocytes
Published in Drug Law Weekly, October 5th, 2004
The presentation, titled "Antisense Inhibition of cFLIP Promotes Transplant Acceptance by Sensitizing Responding T Cells to Undergo Activation Induced Apoptosis," was presented by AVI senior scientist Dan Mourich, PhD. The findings of the study indicate that specific transplant acceptance can be achieved using AVI's antisense approach and that a novel method for promoting transplant survival without long-term immunosuppressive therapy is...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
Source: Drug Law Weekly (2004-10-05)
More Articles from Drug Law Weekly
- American Assn. of Oral & Maxillofacial Surgeons
Hazards of surgery and anesthesia for drug, alcohol abusers presented at meeting - Applera Corp.
GTG reports on the current status of legal action to protect its patents - Cancer Funding
MMA may result in 43%-54% loss in community-based cancer care funds in 2005 - Chiron
Pharma announces settlement in HIV patent dispute with Roche - Drug Importation
Oak Creek, Wisconsin, mayor says he plans to veto Canadian drug proposal - Entropin, Inc.
ENT-103 maker provides progress report and litigation update - More from this issue of Drug Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
